Elective cesarean section for women living with HIV: a systematic review of risks and benefits
- PMID: 28481770
- PMCID: PMC5491238
- DOI: 10.1097/QAD.0000000000001535
Elective cesarean section for women living with HIV: a systematic review of risks and benefits
Abstract
Objective and design: To inform WHO guidelines, we conducted a systematic review and meta-analysis to assess maternal and perinatal outcomes comparing cesarean section (c-section) before labor and rupture of membranes [elective c-section (ECS)] with other modes of delivery for women living with HIV.
Methods: We searched PubMed, CINAHL, Embase, CENTRAL, and previous reviews to identify published trials and observational studies through October 2015. Results were synthesized using random-effects meta-analysis, stratifying for combination antiretroviral therapy (cART), CD4/viral load (VL), delivery at term, and low-income/middle-income countries.
Results: From 2567 citations identified, 36 articles met inclusion criteria. The single randomized trial, published in 1999, reported minimal maternal morbidity and significantly fewer infant HIV infections with ECS [odds ratio (OR) 0.2, 95% confidence interval (CI) 0.0-0.5]. Across observational studies, ECS was associated with increased maternal morbidity compared with vaginal delivery (OR 3.12, 95% CI 2.21-4.41). ECS was also associated with decreased infant HIV infection overall (OR 0.43, 95% CI 0.30-0.63) and in low-income/middle-income countries (OR 0.27, 95% CI 0.16-0.45), but not among women on cART (OR 0.82, 95% CI 0.47-1.43) or with CD4 cell count more than 200/VL less than 400/term delivery (OR 0.59, 95% CI 0.21-1.63). Infant morbidity moderately increased with ECS.
Conclusion: Although ECS may reduce infant HIV infection, this effect was not statistically significant in the context of cART and viral suppression. As ECS poses other risks, routine ECS for all women living with HIV may not be appropriate. Risks and benefits will differ across settings, depending on underlying risks of ECS complications and vertical transmission during delivery. Understanding individual client risks and benefits and respecting women's autonomy remain important.
Figures
Similar articles
-
Efficacy and safety of cesarean delivery for prevention of mother-to-child transmission of HIV-1.Cochrane Database Syst Rev. 2005 Oct 19;(4):CD005479. doi: 10.1002/14651858.CD005479. Cochrane Database Syst Rev. 2005. PMID: 16235405 Review.
-
Cesarean section delivery to prevent vertical transmission of human immunodeficiency virus type 1. Associated risks and other considerations.Ann N Y Acad Sci. 2000 Nov;918:115-21. doi: 10.1111/j.1749-6632.2000.tb05479.x. Ann N Y Acad Sci. 2000. PMID: 11131694 Review.
-
Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.Cochrane Database Syst Rev. 2010 Mar 17;(3):CD008440. doi: 10.1002/14651858.CD008440. Cochrane Database Syst Rev. 2010. PMID: 20238370 Review.
-
Patterns of caesarean section in HIV infected and non-infected women in Malawi: is caesarean section used for PMTCT?BMC Pregnancy Childbirth. 2018 Apr 12;18(1):95. doi: 10.1186/s12884-018-1722-4. BMC Pregnancy Childbirth. 2018. PMID: 29649980 Free PMC article.
-
Cost-effectiveness of cesarean section delivery to prevent mother-to-child transmission of HIV-1.AIDS. 2000 Apr 14;14(6):691-700. doi: 10.1097/00002030-200004140-00008. AIDS. 2000. PMID: 10807192
Cited by
-
Clinical and Biological Risk Factors Associated with Increased Mother-to-Child Transmission of HIV in Two South-East HIV-AIDS Regional Centers in Romania.Medicina (Kaunas). 2022 Feb 11;58(2):275. doi: 10.3390/medicina58020275. Medicina (Kaunas). 2022. PMID: 35208597 Free PMC article.
-
Understanding Viral and Immune Interplay During Vertical Transmission of HIV: Implications for Cure.Front Immunol. 2021 Oct 21;12:757400. doi: 10.3389/fimmu.2021.757400. eCollection 2021. Front Immunol. 2021. PMID: 34745130 Free PMC article. Review.
-
Preventing mother to child transmission of HIV: lessons learned from China.BMC Infect Dis. 2020 Oct 26;20(1):792. doi: 10.1186/s12879-020-05516-3. BMC Infect Dis. 2020. PMID: 33106179 Free PMC article.
-
Impact of the Coronavirus Infection in Pregnancy: A Preliminary Study of 141 Patients.J Obstet Gynaecol India. 2020 Aug;70(4):256-261. doi: 10.1007/s13224-020-01335-3. Epub 2020 Jul 7. J Obstet Gynaecol India. 2020. PMID: 32760169 Free PMC article.
-
ISIDOG Recommendations Concerning COVID-19 and Pregnancy.Diagnostics (Basel). 2020 Apr 22;10(4):243. doi: 10.3390/diagnostics10040243. Diagnostics (Basel). 2020. PMID: 32338645 Free PMC article.
References
-
- The International Perinatal HIV Group. The mode of delivery and the risk of vertical transmission of human immunodeficiency virus type 1: a meta-analysis of 15 prospective cohort studies. N Engl J Med 1999; 340:977–987. - PubMed
-
- World Health Organization. Guideline on when to start antiretroviral therapy and on preexposure prophylaxis for HIV. Geneva, Switzerland: WHO; September 2015. Available from: http://apps.who.int/iris/bitstream/10665/186275/1/9789241509565_eng.pdf?... [Accessed 24 April 2017]
-
- World Health Organization. WHO statement on caesarean section rates 2015. Geneva, Switzerland: WHO; 2015. Available from: http://apps.who.int/iris/bitstream/10665/161442/1/WHO_RHR_15.02_eng.pdf?... [Accessed 24 April 2017]
-
- Read JS, Newell MK. Efficacy and safety of cesarean delivery for prevention of mother-to-child transmission of HIV-1. Cochrane Database Syst Rev 2005; 4: CD005479. - PubMed
Publication types
MeSH terms
Grant support
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous
